[
    {
        "filename": "data/tables/uc_juillerat_2022_tab1.csv",
        "mode": "table",
        "description": "Efficacy of biological treatments according to the line of treatment, earlier exposure, disease phenotype and patient characteristics. ",
        "metadata": {
            "author": "Pascal Juillerat",
            "creator": "Elsevier",
            "file_path": "/mnt/c/Users/QUAN/Desktop/medical-chatbot/data/document_store/uc/juillerat 2022.pdf",
            "page": 3,
            "source": "/mnt/c/Users/QUAN/Desktop/medical-chatbot/data/document_store/uc/juillerat 2022.pdf",
            "subject": "Current Research in Pharmacology and Drug Discovery, 3 (2022) 100104. doi:10.1016/j.crphar.2022.100104",
            "title": "Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom?",
            "total_pages": 9
            }
    },
    {
        "filename": "data/tables/grading_disease_activity_agrawal.csv",
        "mode": "table",
        "description": "Stratification of inflammatory bowel disease risk of progression based on disease severity and activity. BMI, body mass index; CDAI, Crohns Disease Activity Index; ESR, erythrocyte sedimentation rate; UCEIS, Ulcerative Colitis Endoscopic Index of Severity.",
        "metadata": {
            "author": "Manasi Agrawal",
            "creator": "Elsevier",
            "file_path": "/mnt/c/Users/QUAN/Desktop/medical-chatbot/data/document_store/uc/agrawal.pdf",
            "page": 5,
            "source": "/mnt/c/Users/QUAN/Desktop/medical-chatbot/data/document_store/uc/agrawal.pdf",
            "subject": "Gastroenterology, 161 (2021) 47-65. doi:10.1053/j.gastro.2021.04.063",
            "title": "Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A Users Guide for Adult and Pediatric Gastroenterologists",
            "total_pages": 19
            }
    },
    {
        "filename": "data/tables/recently_diagnosed_uc_agrawal.csv",
        "mode": "table",
        "description": "Therapeutic strategies for the management of recentlydiagnosedulcerative colitis. IMMs include thiopurines and methotrexate. 5-ASA, 5-amino salicylic acid; ASUC, acute severe ulcerative colitis; IPAA, ileal pouch anal anastomosis.",
        "metadata": {
            "author": "Manasi Agrawal",
            "creator": "Elsevier",
            "file_path": "/mnt/c/Users/QUAN/Desktop/medical-chatbot/data/document_store/uc/agrawal.pdf",
            "page": 7,
            "source": "/mnt/c/Users/QUAN/Desktop/medical-chatbot/data/document_store/uc/agrawal.pdf",
            "subject": "Gastroenterology, 161 (2021) 47-65. doi:10.1053/j.gastro.2021.04.063",
            "title": "Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A Users Guide for Adult and Pediatric Gastroenterologists",
            "total_pages": 19
            }
    }
]